+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lurasidone Hydrochloride Tablet Market - Global Forecast 2025-2030- Product Image
Lurasidone Hydrochloride Tablet Market - Global Forecast 2025-2030- Product Image
Sale

Lurasidone Hydrochloride Tablet Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6137998
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Lurasidone Hydrochloride tablets have emerged as a critical intervention in the management of neuropsychiatric conditions, offering clinicians a balance of efficacy, tolerability, and patient adherence benefits. This executive summary explores the therapeutic role of these tablets in addressing bipolar depression and schizophrenia, underscoring their pharmacological profile, safety considerations, and the evolving spectrum of patient experiences. As clinical evidence continues to validate the unique receptor binding properties of lurasidone, the tablet formulation has become a preferred option for many healthcare professionals seeking targeted neurochemical modulation with minimal metabolic impact.

In parallel, shifts in healthcare delivery frameworks and patient-centric care models have heightened the emphasis on dose flexibility, formulation variety, and streamlined distribution channels. This introduction establishes the groundwork for a strategic analysis that navigates the complexities of the pharmaceutical landscape, focusing on regulatory developments, supply chain dynamics, and competitive forces. By contextualizing the pivotal characteristics of Lurasidone Hydrochloride tablets and their adoption pathways, this section sets the stage for a comprehensive exploration of market transformations, segmentation insights, and region-specific factors that will shape future decision-making for stakeholders.

Examining the Paradigm Shifts Influencing Lurasidone Hydrochloride Adoption Through Technological Advances Regulatory Changes and Clinical Insights

The landscape surrounding Lurasidone Hydrochloride tablets has witnessed profound shifts driven by advancements in regulatory frameworks, digital health integration, and an intensified focus on personalized medicine. Recent breakthroughs in clinical trial design have refined patient stratification criteria, enabling more targeted efficacy assessments in bipolar depression and schizophrenia cohorts. Consequently, regulatory approvals have been expeditiously aligned with robust real-world evidence initiatives, fostering an environment of accelerated pharmacovigilance and adaptive labeling practices.

Moreover, the integration of digital adherence solutions and telehealth consultations has reshaped how patients access and manage their treatment regimens. Electronic health records and remote monitoring platforms now facilitate continuous data collection, granting healthcare providers deeper insights into dosing patterns and patient responses. Coupled with advancements in formulation science that enhance bioavailability and minimize adverse events, these transformative shifts have collectively redefined treatment paradigms. As a result, industry stakeholders are compelled to recalibrate their strategies around patient support programs, digital engagement platforms, and collaborative research ventures to maintain competitive advantage.

Assessing the Comprehensive Repercussions of 2025 US Tariff Policies on Lurasidone Hydrochloride Supply Chains Production Costs and Market Dynamics

The introduction of new tariff measures by the United States in 2025 has had a cumulative impact on the production and distribution of Lurasidone Hydrochloride tablets, particularly in relation to active pharmaceutical ingredient imports and finished dosage form exports. Tariff adjustments on precursor chemicals and excipients have translated into increased input costs for manufacturers, prompting a reassessment of sourcing strategies and contractual arrangements. As companies grapple with these additional duties, cost containment efforts have intensified, driving negotiations for long-term supply agreements and collaborative risk-sharing frameworks.

Furthermore, distribution partners have encountered upward pressure on logistical expenses, as cross-border trade compliance and customs clearance protocols become more complex. This environment has spurred a trend toward regional manufacturing alliances and nearshoring initiatives aimed at mitigating tariff exposure and ensuring supply chain resilience. Consequently, stakeholders are investing in dual-sourcing arrangements and exploring alternative material suppliers to preserve continuity of supply. These strategic responses underscore the necessity for agile operational models capable of navigating evolving trade regulations while safeguarding patient access to Lurasidone Hydrochloride tablet therapies.

Comprehensive Segmentation Framework Unlocking Key Market Dimensions for Lurasidone Hydrochloride Tablet Adoption and Growth Strategies

A nuanced understanding of segmentation is imperative for stakeholders seeking to optimize product offerings and engagement strategies within the Lurasidone Hydrochloride tablet domain. When considering indication, the therapeutic scope extends across bipolar depression and schizophrenia, with each condition presenting distinct clinical endpoints, treatment durations, and co-morbidity profiles. This diversity influences prescriber preferences, patient education initiatives, and long-term adherence programs. Attention to dosage strength reveals a spectrum ranging from 20 mg through 80 mg, enabling clinicians to tailor regimens based on symptom severity, pharmacokinetic tolerability, and metabolic considerations.

Formulation choices further differentiate market dynamics, as film coated tablets cater to patients prioritizing ease of swallowing, while orally disintegrating tablets address the needs of individuals experiencing dysphagia or requiring rapid onset of action. Distribution channel analysis uncovers the strategic importance of hospital pharmacies for in-patient initiation, online pharmacies for convenience-driven refill programs, and retail pharmacies for community-based touchpoints. End user segmentation spans adult, geriatric, and pediatric patients, each demographic presenting unique safety monitoring requirements, dosage adjustments, and caregiver support frameworks. Finally, the presence of branded and generic product types shapes competitive intensity, pricing strategies, and therapeutic substitution policies. By integrating these segmentation lenses, organizations can refine positioning tactics and align value propositions with stakeholder priorities across the product lifecycle.

Deciphering Regional Dynamics Shaping Lurasidone Hydrochloride Tablet Adoption Trends Across the Americas EMEA and Asia-Pacific Healthcare Landscapes

Regional dynamics play a pivotal role in determining the uptake and accessibility of Lurasidone Hydrochloride tablets across diverse healthcare ecosystems. In the Americas, heterogeneous reimbursement structures and private payer models drive adoption trends, with a strong focus on outcomes-based agreements and value demonstration initiatives. Patient assistance programs and specialty pharmacy collaborations are increasingly leveraged to navigate coverage complexities, ensuring that clinicians can prescribe optimal dosage strengths with minimal financial barriers.

In the Europe, Middle East & Africa region, regulatory harmonization efforts coupled with stringent pharmacoeconomic assessments shape market entry strategies. Reference pricing systems and health technology appraisals necessitate robust cost-effectiveness data, while regional manufacturing hubs and parallel trade considerations influence supply chain configurations. Collaborative research networks spanning EU member states and Middle Eastern centers further accelerate knowledge exchange on long-term safety outcomes.

Across Asia-Pacific, growing awareness of mental health conditions and expanding healthcare infrastructure are driving demand for innovative neuropsychiatric therapies. National essential medicines lists and public tender processes guide procurement decisions, with film coated and orally disintegrating formulations demonstrating distinct market penetration based on local prescribing habits. As healthcare payers in emerging economies invest in mental health services, the competitive landscape evolves rapidly, underscoring the need for targeted market access strategies that resonate with regional policy priorities and clinical guidelines.

Profiling Leading and Emerging Companies Driving Innovation and Competitive Dynamics in the Lurasidone Hydrochloride Tablet Sector

Key industry participants are intensifying efforts to differentiate their portfolios through research collaborations, strategic licensing agreements, and patient-centric service models. Established innovators have expanded their footprint in the Lurasidone Hydrochloride tablet segment by strengthening clinical trial networks and pursuing label extensions for specific patient subpopulations. Concurrently, generic manufacturers are streamlining their production lines and leveraging scale efficiencies to introduce cost-competitive alternatives without compromising quality standards.

Strategic partnerships between pharmaceutical companies and contract development organizations have yielded more agile route-to-market pathways, enabling rapid formulation optimization and accelerated regulatory submissions. Additionally, collaborative ventures with academic centers and psychiatric institutes have fostered the generation of real-world evidence that substantiates therapeutic value and informs post-approval safety monitoring. These combined efforts have elevated the competitive dynamics within the sector, prompting stakeholders to continuously refine their commercialization approaches and capitalize on unmet needs in both established and emerging territories.

Strategic Action Plan Offering Targeted Recommendations to Enhance Market Positioning and Operational Efficiency in Lurasidone Hydrochloride Tablet Development

Industry leaders should prioritize the development of comprehensive patient support ecosystems that integrate digital adherence monitoring, telepsychiatry services, and tailored educational materials. By leveraging real-time data analytics, organizations can identify adherence challenges early and deploy targeted interventions, thereby enhancing treatment persistence and overall outcomes. Moreover, diversifying supply chain footprints through multi-regional manufacturing sites and collaborative procurement frameworks will help mitigate tariff-driven cost pressures and reinforce supply continuity.

Investment in robust real-world studies will yield critical insights into long-term safety and comparative effectiveness, supporting value-based contracting discussions with payers. Engaging key opinion leaders and forming clinical advisory boards can further amplify advocacy efforts and inform product positioning across therapeutic indications. Finally, aligning commercial strategies with evolving digital health trends and reimbursement innovations will position stakeholders to navigate future shifts in healthcare delivery models, ensuring sustained growth and market relevance.

Articulating the Rigorous Multi-Source Research Methodology Underpinning the Comprehensive Analysis of the Lurasidone Hydrochloride Tablet Market

This analysis is grounded in a rigorous multi-source research methodology encompassing primary and secondary data collection. Primary insights were garnered through in-depth interviews with clinicians, payers, supply chain experts, and patient advocacy representatives, providing qualitative perspectives on treatment patterns, access barriers, and formulary considerations. Secondary sources included peer-reviewed literature, regulatory agency publications, industry whitepapers, and company disclosures, which were systematically synthesized to validate key trends and developments.

Quantitative data inputs were analyzed using statistical tools to identify distribution channel shifts, regional adoption rates, and competitive activity markers. A cross-functional team of pharmacoeconomic analysts, market strategists, and clinical specialists conducted triangulation exercises to reconcile disparate data points and ensure analytical robustness. This hybrid approach has yielded a comprehensive view of the Lurasidone Hydrochloride tablet landscape, supporting actionable insights and strategic guidance for stakeholders across the pharmaceutical value chain.

Synthesis of Key Insights Emphasizing Future Directions Challenges and Opportunities for Stakeholders in the Lurasidone Hydrochloride Tablet Ecosystem

The synthesis of findings underscores the multifaceted forces shaping the Lurasidone Hydrochloride tablet ecosystem, from evolving clinical guidelines and patient engagement innovations to trade policy implications and regional access dynamics. Stakeholders must embrace a collaborative mindset, forging partnerships that span research institutions, payer organizations, and technology providers to navigate emerging challenges and capitalize on growth opportunities.

Future trajectories will hinge on the ability to demonstrate long-term therapeutic value through real-world evidence, adapt to shifting reimbursement frameworks, and harness digital health platforms for enhanced patient support. As the competitive landscape intensifies, the differentiation of product offerings, optimization of supply chains, and alignment with stakeholder priorities will determine market leadership. By leveraging the insights presented in this executive summary, organizations can chart informed pathways that ensure sustained adoption and improved patient outcomes for Lurasidone Hydrochloride tablet therapies.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Indication
    • Bipolar Depression
    • Schizophrenia
  • Dosage Strength
    • 20 Mg
    • 40 Mg
    • 60 Mg
    • 80 Mg
  • Formulation
    • Film Coated Tablet
    • Orally Disintegrating Tablet
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • End User
    • Adult Patient
    • Geriatric Patient
    • Pediatric Patient
  • Product Type
    • Branded
    • Generic
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Apotex Corp.
  • Lupin Limited
  • Aurobindo Pharma Limited
  • Torrent Pharmaceuticals Limited
  • Glenmark Pharmaceuticals Limited
  • Cipla Limited
  • Zydus Lifesciences Limited

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in generic lurasidone hydrochloride tablet launches post patent expiration driving price competition
5.2. Increasing adoption of extended release lurasidone formulations to improve patient adherence rates
5.3. Rising integration of real world evidence studies to support lurasidone hydrochloride labeling updates
5.4. Expanding market access through emerging market approvals and tailored pricing strategies in Asia
5.5. Growing focus on combination therapies pairing lurasidone with digital therapeutics for enhanced outcomes
5.6. Heightened scrutiny of supply chain resilience amid global API shortages affecting lurasidone production
5.7. Advancements in pharmacogenomic profiling guiding personalized lurasidone dosage optimization for patients
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lurasidone Hydrochloride Tablet Market, by Indication
8.1. Introduction
8.2. Bipolar Depression
8.3. Schizophrenia
9. Lurasidone Hydrochloride Tablet Market, by Dosage Strength
9.1. Introduction
9.2. 20 Mg
9.3. 40 Mg
9.4. 60 Mg
9.5. 80 Mg
10. Lurasidone Hydrochloride Tablet Market, by Formulation
10.1. Introduction
10.2. Film Coated Tablet
10.3. Orally Disintegrating Tablet
11. Lurasidone Hydrochloride Tablet Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Lurasidone Hydrochloride Tablet Market, by End User
12.1. Introduction
12.2. Adult Patient
12.3. Geriatric Patient
12.4. Pediatric Patient
13. Lurasidone Hydrochloride Tablet Market, by Product Type
13.1. Introduction
13.2. Branded
13.3. Generic
14. Americas Lurasidone Hydrochloride Tablet Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Lurasidone Hydrochloride Tablet Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Lurasidone Hydrochloride Tablet Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Sumitomo Dainippon Pharma Co., Ltd.
17.3.2. Teva Pharmaceutical Industries Ltd.
17.3.3. Viatris Inc.
17.3.4. Apotex Corp.
17.3.5. Lupin Limited
17.3.6. Aurobindo Pharma Limited
17.3.7. Torrent Pharmaceuticals Limited
17.3.8. Glenmark Pharmaceuticals Limited
17.3.9. Cipla Limited
17.3.10. Zydus Lifesciences Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. LURASIDONE HYDROCHLORIDE TABLET MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. LURASIDONE HYDROCHLORIDE TABLET MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. LURASIDONE HYDROCHLORIDE TABLET MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. LURASIDONE HYDROCHLORIDE TABLET MARKET: RESEARCHAI
FIGURE 28. LURASIDONE HYDROCHLORIDE TABLET MARKET: RESEARCHSTATISTICS
FIGURE 29. LURASIDONE HYDROCHLORIDE TABLET MARKET: RESEARCHCONTACTS
FIGURE 30. LURASIDONE HYDROCHLORIDE TABLET MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LURASIDONE HYDROCHLORIDE TABLET MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY BIPOLAR DEPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY BIPOLAR DEPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY 20 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY 20 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY 40 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY 40 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY 60 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY 60 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY 80 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY 80 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FILM COATED TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FILM COATED TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY ORALLY DISINTEGRATING TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY ORALLY DISINTEGRATING TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY ADULT PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY ADULT PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY GERIATRIC PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY GERIATRIC PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PEDIATRIC PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PEDIATRIC PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 81. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 82. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 83. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 84. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 85. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 86. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 87. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. CANADA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 94. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 95. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 96. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 97. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 98. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 99. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 158. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 159. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 160. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 161. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. GERMANY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 170. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 171. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 172. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 173. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. FRANCE LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 194. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 195. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 196. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 197. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. ITALY LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 206. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 207. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 208. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 209. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. SPAIN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 254. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 255. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 256. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 257. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. DENMARK LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 278. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 279. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 280. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 281. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. QATAR LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 290. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 291. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 292. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 293. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. FINLAND LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN LURASIDONE HYDROCHLORIDE TABLET MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN LURASIDONE HYDROCHLORIDE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Lurasidone Hydrochloride Tablet market report include:
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Apotex Corp.
  • Lupin Limited
  • Aurobindo Pharma Limited
  • Torrent Pharmaceuticals Limited
  • Glenmark Pharmaceuticals Limited
  • Cipla Limited
  • Zydus Lifesciences Limited

Related Topics

Related Reports

Lurasidone Hydrochloride Generics Market - Global Forecast to 2030 - Product Image

Lurasidone Hydrochloride Generics Market - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Lurasidone (CAS 367514-87-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Lurasidone (CAS 367514-87-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Fluoxetine Hydrochloride Dispersible Tablets Market - Global Forecast 2025-2030 - Product Image

Fluoxetine Hydrochloride Dispersible Tablets Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Imipramine Hydrochloride Tablet Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Image

Imipramine Hydrochloride Tablet Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • 74 Pages
  • Global
From
Tramadol Hydrochloride Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Tramadol Hydrochloride Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.